146 related articles for article (PubMed ID: 20537977)
21. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
22. Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease.
Guichelaar MM; Malinchoc M; Sibonga JD; Clarke BL; Hay JE
J Bone Miner Res; 2003 Dec; 18(12):2190-9. PubMed ID: 14672354
[TBL] [Abstract][Full Text] [Related]
23. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
Hodsman A; Adachi J; Olszynski W
CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
[TBL] [Abstract][Full Text] [Related]
24. Management of osteoporosis in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Vleggaar FP; Schalm SW
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):629-41. PubMed ID: 10976019
[TBL] [Abstract][Full Text] [Related]
25. Osteoporosis after liver transplantation.
Compston JE
Liver Transpl; 2003 Apr; 9(4):321-30. PubMed ID: 12682881
[TBL] [Abstract][Full Text] [Related]
26. Does diabetes increase the risk for fractures after solid organ transplantation? A nested case-control study.
Rakel A; Sheehy O; Rahme E; Lelorier J
J Bone Miner Res; 2007 Dec; 22(12):1878-84. PubMed ID: 17680725
[TBL] [Abstract][Full Text] [Related]
27. Diabetes mellitus a risk for osteoporosis?
Leidig-Bruckner G; Ziegler R
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S493-514. PubMed ID: 11460594
[TBL] [Abstract][Full Text] [Related]
28. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
[TBL] [Abstract][Full Text] [Related]
29. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
30. Prevention of osteoporosis and fractures.
Ullom-Minnich P
Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
[TBL] [Abstract][Full Text] [Related]
31. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
32. Balloon kyphoplasty for vertebral compression fractures in solid organ transplant recipients: results of treatment and comparison with primary osteoporotic vertebral compression fractures.
Deen HG; Aranda-Michel J; Reimer R; Miller DA; Putzke JD
Spine J; 2006; 6(5):494-9. PubMed ID: 16934717
[TBL] [Abstract][Full Text] [Related]
33. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
Leidig-Bruckner G; Ziegler R
Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
[TBL] [Abstract][Full Text] [Related]
35. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, etiology, and diagnosis of osteoporosis.
Lane NE
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
[TBL] [Abstract][Full Text] [Related]
37. Strategies for treatment to prevent fragility fractures in postmenopausal women.
Geusens P
Best Pract Res Clin Rheumatol; 2009 Dec; 23(6):727-40. PubMed ID: 19945685
[TBL] [Abstract][Full Text] [Related]
38. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Ikeda K; Kumada H
J Med Virol; 2008 Jul; 80(7):1302-7. PubMed ID: 18461628
[TBL] [Abstract][Full Text] [Related]
39. [Osteoporosis].
Ziegler R
Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1051-5. PubMed ID: 7939067
[TBL] [Abstract][Full Text] [Related]
40. [Secondary prevention of osteoporosis and identification of high risk patients].
Lehmann R; Pfeifer M; Minne H; Allolio B
Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):445-51. PubMed ID: 10996933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
